ANALISIS BIAYA DAN OUTCOME TERAPI PENGGUNAAN ANTIPSIKOTIKA PADA PASIEN SKIZOFRENIA RAWAT INAP RSD MADANI PROVINSI SULAWESI TENGAH TAHUN 2015

KUSDIANA, ERRY (2015) ANALISIS BIAYA DAN OUTCOME TERAPI PENGGUNAAN ANTIPSIKOTIKA PADA PASIEN SKIZOFRENIA RAWAT INAP RSD MADANI PROVINSI SULAWESI TENGAH TAHUN 2015. Tesis thesis, Universitas Setia Budi Surakarta.

[img] Text
INTISARI.pdf

Download (173kB)
[img] Text
SBF 111340253.pdf
Restricted to Repository staff only

Download (2MB) | Request a copy

Abstract

Schizophrenia is a chronic disease taking long treatment time and high cost. Treatment cost and effectiveness of schizophrenia therapy are highly dependent on type of antipsychotics used. The objective of research was to find a description on antipsychotics use, average treatment cost of schizophrenic patients, and the outcome of antipsychotic therapy in schizophrenic patients treated in inpatient units. This study was a descriptive research according to hospital perspective, by taking the sample retrospectively on February to April 2015. The data analysis was carried out using descriptive analysis to find out the description of antipsychotic use, total cost of schizophrenia disease and therapy outcome in the form of decreased (delta, ) PANSS score, increased weight, length of stay in hospital and extra-pyramidal incidence frequency in schizophrenic inpatients in RSD (Local Hospital) Madani Centre of Sulawesi Province. The result of research showed that the prevalence of schizophrenia disease was 85 patients. Antipsychotics commonly used were haloperidol (43.53%), risperidon (21.18%), and chlorpromazine (15.29%). The average cost of schizophrenic therapy was IDR 2,810,329.94, the average cost of typical antipsychotic group was IDR 2,720,538.27 with therapeutic outcome:  PANSS score of 53.53; weight increased of 0.32 kg; LOS of 17,24 days; extra-pyramidal incidence frequency was 27.12%, the average cost of atypical antipsychotic group was IDR 2,728,091.69 with therapeutic outcome:  PANSS score of 52.79; weight increased of 0.43 kg; LOS of 15.53 days; extra-pyramidal incidence frequency was 10.53%,and the cost of antipsychotic group (combination of typical and atypical) was IDR 3,790,363.52 with therapeutic outcome:  PANSS score of 59.57; weight increased of 0.47 kg; LOS of 19.29 days; extra-pyramidal incidence frequency was 0%. Keywords: Antipsychotics, Schizophrenia, total cost, therapy outcome

Item Type: Thesis (Tesis)
Uncontrolled Keywords: Antipsychotics, Schizophrenia, total cost, therapy outcome
Subjects: H Social Sciences > HG Finance
R Medicine > RS Pharmacy and materia medica
Divisions: Fakultas Farmasi > Prodi S2 Farmasi
Depositing User: magdalena kartika ningsih
Date Deposited: 20 Feb 2020 07:27
Last Modified: 20 Feb 2020 07:27
URI: http://repo.setiabudi.ac.id/id/eprint/2316

Actions (login required)

View Item View Item